Orgenesis Inc Asset Resilience Ratio

Latest as of December 2021: 0.25%

Orgenesis Inc asset resilience ratio. Orgenesis Inc (ORGS) has an Asset Resilience Ratio of 0.25% as of December 2021. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See operational self-sufficiency of Orgenesis Inc to measure how many days the company can operate on defensive assets alone.

Liquid Assets

$152.00K

Cash + Short-term Investments

Total Assets

$59.84 Million

All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio of Orgenesis Inc (2021–2021)

Asset resilience ratio of Orgenesis Inc from 2021 to 2021. This chart shows how Orgenesis Inc's Asset Resilience Ratio has changed over time. Read how much debt does Orgenesis Inc carry for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Orgenesis Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see how large is Orgenesis Inc's balance sheet.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	$0.00	0%
Short-term Investments	$152.00K	0.25%
Total Liquid Assets	$152.00K	0.25%

Asset Resilience Insights

Limited Liquidity: Orgenesis Inc maintains only 0.25% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Orgenesis Inc Industry Peers by Asset Resilience Ratio

Compare Orgenesis Inc's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Hyloris Developmentsen Sa BR:HYL	Biotechnology	1.36%
Biomarin Pharmaceutical Inc NASDAQ:BMRN	Biotechnology	0.00%
Oruka Therapeutics, Inc. NASDAQ:ORKA	Biotechnology	53.11%
Gempharmatech Co. Ltd. A SHG:688046	Biotechnology	23.95%
Vor Biopharma Inc NASDAQ:VOR	Biotechnology	74.48%
Inventiva S.A PA:IVA	Biotechnology	52.73%
Sunmax Biotechnology Co Ltd TWO:4728	Biotechnology	10.53%
Guangdong VTR Bio-Tech Co Ltd SHE:300381	Biotechnology	4.98%

Orgenesis Inc Asset Resilience Ratio by Year (2021–2021)

Orgenesis Inc asset resilience ratio by year from 2021 to 2021. The table below shows the annual Asset Resilience Ratio data for Orgenesis Inc.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2021-12-31	0.25%	$152.00K	$59.84 Million	--

pp = percentage points

About Orgenesis Inc

NASDAQ:ORGS USA Biotechnology

Market Cap

$10.08 Million

Market Cap Rank

#26980 Global

#5611 in USA

Share Price

$1.95

Change (1 day)

+0.00%

52-Week Range

$1.95 - $1.95

All Time High

$2.09